Report Overview
The gene and cell therapy Contract Development and Manufacturing Organization (CDMO) market is a specialized segment within the broader biopharmaceutical outsourcing industry, focusing on providing end-to-end services for the development, manufacturing, and commercialization of advanced therapies. These therapies include gene therapies, cell-based therapies (such as CAR-T and stem cell therapies), and other regenerative medicine products. CDMOs in this space offer expertise in viral vector production (e.g., lentiviral and AAV vectors), cell processing, plasmid DNA manufacturing, and analytical testing, catering to biotech firms and pharmaceutical companies that lack in-house capabilities or seek to accelerate time-to-market. The market is driven by the rapid growth of gene and cell therapy pipelines, regulatory advancements, and increasing investment in personalized medicine, with CDMOs playing a critical role in overcoming complex manufacturing challenges, ensuring scalability, and maintaining compliance with stringent quality standards.
This report provides a deep insight into the global Gene Cell Therapy CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gene Cell Therapy CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gene Cell Therapy CDMO market in any manner.
Global Gene Cell Therapy CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Catalent
Lonza
Thermo Fisher
ACG Biologics
Charles River
Oxford Biomedica
Novartis
OBiO
GenScript
Pharmaron
Porton
Market Segmentation (by Type)
Immune Cells
Stem Cell
Viral Vector
Plasmid DNA
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gene Cell Therapy CDMO Market
Overview of the regional outlook of the Gene Cell Therapy CDMO Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gene Cell Therapy CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gene Cell Therapy CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Cell Therapy CDMO
1.2 Key Market Segments
1.2.1 Gene Cell Therapy CDMO Segment by Type
1.2.2 Gene Cell Therapy CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene Cell Therapy CDMO Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Cell Therapy CDMO Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gene Cell Therapy CDMO Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene Cell Therapy CDMO Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Gene Cell Therapy CDMO Product Life Cycle
3.3 Global Gene Cell Therapy CDMO Sales by Manufacturers (2020-2025)
3.4 Global Gene Cell Therapy CDMO Revenue Market Share by Manufacturers (2020-2025)
3.5 Gene Cell Therapy CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gene Cell Therapy CDMO Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Gene Cell Therapy CDMO Market Competitive Situation and Trends
3.8.1 Gene Cell Therapy CDMO Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gene Cell Therapy CDMO Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Gene Cell Therapy CDMO Industry Chain Analysis
4.1 Gene Cell Therapy CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Cell Therapy CDMO Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gene Cell Therapy CDMO Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gene Cell Therapy CDMO Market
5.7 ESG Ratings of Leading Companies
6 Gene Cell Therapy CDMO Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Cell Therapy CDMO Sales Market Share by Type (2020-2025)
6.3 Global Gene Cell Therapy CDMO Market Size Market Share by Type (2020-2025)
6.4 Global Gene Cell Therapy CDMO Price by Type (2020-2025)
7 Gene Cell Therapy CDMO Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Cell Therapy CDMO Market Sales by Application (2020-2025)
7.3 Global Gene Cell Therapy CDMO Market Size (M USD) by Application (2020-2025)
7.4 Global Gene Cell Therapy CDMO Sales Growth Rate by Application (2020-2025)
8 Gene Cell Therapy CDMO Market Sales by Region
8.1 Global Gene Cell Therapy CDMO Sales by Region
8.1.1 Global Gene Cell Therapy CDMO Sales by Region
8.1.2 Global Gene Cell Therapy CDMO Sales Market Share by Region
8.2 Global Gene Cell Therapy CDMO Market Size by Region
8.2.1 Global Gene Cell Therapy CDMO Market Size by Region
8.2.2 Global Gene Cell Therapy CDMO Market Size Market Share by Region
8.3 North America
8.3.1 North America Gene Cell Therapy CDMO Sales by Country
8.3.2 North America Gene Cell Therapy CDMO Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gene Cell Therapy CDMO Sales by Country
8.4.2 Europe Gene Cell Therapy CDMO Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gene Cell Therapy CDMO Sales by Region
8.5.2 Asia Pacific Gene Cell Therapy CDMO Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gene Cell Therapy CDMO Sales by Country
8.6.2 South America Gene Cell Therapy CDMO Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gene Cell Therapy CDMO Sales by Region
8.7.2 Middle East and Africa Gene Cell Therapy CDMO Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Gene Cell Therapy CDMO Market Production by Region
9.1 Global Production of Gene Cell Therapy CDMO by Region(2020-2025)
9.2 Global Gene Cell Therapy CDMO Revenue Market Share by Region (2020-2025)
9.3 Global Gene Cell Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gene Cell Therapy CDMO Production
9.4.1 North America Gene Cell Therapy CDMO Production Growth Rate (2020-2025)
9.4.2 North America Gene Cell Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gene Cell Therapy CDMO Production
9.5.1 Europe Gene Cell Therapy CDMO Production Growth Rate (2020-2025)
9.5.2 Europe Gene Cell Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gene Cell Therapy CDMO Production (2020-2025)
9.6.1 Japan Gene Cell Therapy CDMO Production Growth Rate (2020-2025)
9.6.2 Japan Gene Cell Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gene Cell Therapy CDMO Production (2020-2025)
9.7.1 China Gene Cell Therapy CDMO Production Growth Rate (2020-2025)
9.7.2 China Gene Cell Therapy CDMO Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Catalent
10.1.1 Catalent Basic Information
10.1.2 Catalent Gene Cell Therapy CDMO Product Overview
10.1.3 Catalent Gene Cell Therapy CDMO Product Market Performance
10.1.4 Catalent Business Overview
10.1.5 Catalent SWOT Analysis
10.1.6 Catalent Recent Developments
10.2 Lonza
10.2.1 Lonza Basic Information
10.2.2 Lonza Gene Cell Therapy CDMO Product Overview
10.2.3 Lonza Gene Cell Therapy CDMO Product Market Performance
10.2.4 Lonza Business Overview
10.2.5 Lonza SWOT Analysis
10.2.6 Lonza Recent Developments
10.3 Thermo Fisher
10.3.1 Thermo Fisher Basic Information
10.3.2 Thermo Fisher Gene Cell Therapy CDMO Product Overview
10.3.3 Thermo Fisher Gene Cell Therapy CDMO Product Market Performance
10.3.4 Thermo Fisher Business Overview
10.3.5 Thermo Fisher SWOT Analysis
10.3.6 Thermo Fisher Recent Developments
10.4 ACG Biologics
10.4.1 ACG Biologics Basic Information
10.4.2 ACG Biologics Gene Cell Therapy CDMO Product Overview
10.4.3 ACG Biologics Gene Cell Therapy CDMO Product Market Performance
10.4.4 ACG Biologics Business Overview
10.4.5 ACG Biologics Recent Developments
10.5 Charles River
10.5.1 Charles River Basic Information
10.5.2 Charles River Gene Cell Therapy CDMO Product Overview
10.5.3 Charles River Gene Cell Therapy CDMO Product Market Performance
10.5.4 Charles River Business Overview
10.5.5 Charles River Recent Developments
10.6 Oxford Biomedica
10.6.1 Oxford Biomedica Basic Information
10.6.2 Oxford Biomedica Gene Cell Therapy CDMO Product Overview
10.6.3 Oxford Biomedica Gene Cell Therapy CDMO Product Market Performance
10.6.4 Oxford Biomedica Business Overview
10.6.5 Oxford Biomedica Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Gene Cell Therapy CDMO Product Overview
10.7.3 Novartis Gene Cell Therapy CDMO Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 OBiO
10.8.1 OBiO Basic Information
10.8.2 OBiO Gene Cell Therapy CDMO Product Overview
10.8.3 OBiO Gene Cell Therapy CDMO Product Market Performance
10.8.4 OBiO Business Overview
10.8.5 OBiO Recent Developments
10.9 GenScript
10.9.1 GenScript Basic Information
10.9.2 GenScript Gene Cell Therapy CDMO Product Overview
10.9.3 GenScript Gene Cell Therapy CDMO Product Market Performance
10.9.4 GenScript Business Overview
10.9.5 GenScript Recent Developments
10.10 Pharmaron
10.10.1 Pharmaron Basic Information
10.10.2 Pharmaron Gene Cell Therapy CDMO Product Overview
10.10.3 Pharmaron Gene Cell Therapy CDMO Product Market Performance
10.10.4 Pharmaron Business Overview
10.10.5 Pharmaron Recent Developments
10.11 Porton
10.11.1 Porton Basic Information
10.11.2 Porton Gene Cell Therapy CDMO Product Overview
10.11.3 Porton Gene Cell Therapy CDMO Product Market Performance
10.11.4 Porton Business Overview
10.11.5 Porton Recent Developments
11 Gene Cell Therapy CDMO Market Forecast by Region
11.1 Global Gene Cell Therapy CDMO Market Size Forecast
11.2 Global Gene Cell Therapy CDMO Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gene Cell Therapy CDMO Market Size Forecast by Country
11.2.3 Asia Pacific Gene Cell Therapy CDMO Market Size Forecast by Region
11.2.4 South America Gene Cell Therapy CDMO Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gene Cell Therapy CDMO by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Gene Cell Therapy CDMO Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gene Cell Therapy CDMO by Type (2026-2033)
12.1.2 Global Gene Cell Therapy CDMO Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gene Cell Therapy CDMO by Type (2026-2033)
12.2 Global Gene Cell Therapy CDMO Market Forecast by Application (2026-2033)
12.2.1 Global Gene Cell Therapy CDMO Sales (K Units) Forecast by Application
12.2.2 Global Gene Cell Therapy CDMO Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
